Variant report
Variant | esv2631282 |
---|---|
Chromosome Location | chr11:86964171-86965449 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528247052 | chr11:86964177-86964178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs188830283 | chr11:86964199-86964200 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114075643 | chr11:86964246-86964247 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377645513 | chr11:86964338-86964339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs687197 | chr11:86964357-86964358 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs199705600 | chr11:86964386-86964387 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs666043 | chr11:86964415-86964416 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs687568 | chr11:86964421-86964422 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs371206177 | chr11:86964450-86964451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553344509 | chr11:86964459-86964460 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573491148 | chr11:86964488-86964489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371168725 | chr11:86964554-86964555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535619879 | chr11:86964564-86964565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1686166 | chr11:86964598-86964599 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs181197796 | chr11:86964623-86964624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185413491 | chr11:86964666-86964667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145095035 | chr11:86964688-86964689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543146066 | chr11:86964689-86964690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563285783 | chr11:86964722-86964723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576809028 | chr11:86964724-86964725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545785707 | chr11:86964725-86964726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559342882 | chr11:86964726-86964727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs60680451 | chr11:86964733-86964734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2509561 | chr11:86964759-86964760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142385092 | chr11:86964811-86964812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561902013 | chr11:86964820-86964821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531019736 | chr11:86964825-86964826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146374418 | chr11:86964898-86964899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529018824 | chr11:86964922-86964923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539411207 | chr11:86964937-86964938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530148440 | chr11:86964952-86964953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs61904477 | chr11:86964961-86964962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111565568 | chr11:86964962-86964963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61904478 | chr11:86964963-86964964 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112411652 | chr11:86964964-86964965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs61904479 | chr11:86964965-86964966 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs2459960 | chr11:86964991-86964992 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs368293390 | chr11:86965013-86965014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370638489 | chr11:86965100-86965101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs2459959 | chr11:86965161-86965162 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs180734428 | chr11:86965187-86965188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576878780 | chr11:86965245-86965246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576949294 | chr11:86965287-86965288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368482527 | chr11:86965313-86965314 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559319186 | chr11:86965322-86965323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534649964 | chr11:86965341-86965342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372328304 | chr11:86965347-86965348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs2030234 | chr11:86965391-86965392 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs187213412 | chr11:86965399-86965400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561863301 | chr11:86965425-86965426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Attention deficit hyperactivity disorder | 22241247 | CNVD |
Breast cancer | 21958427 | CNVD |
Breast cancer | 17133270 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Obesity | 20622171 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:86961400-86967800 | Weak transcription | NHDF-Ad | bronchial |
2 | chr11:86962400-86972000 | Weak transcription | Primary T cells from cord blood | blood |
3 | chr11:86962800-86977600 | Weak transcription | K562 | blood |
4 | chr11:86963000-86976200 | Weak transcription | Colon Smooth Muscle | Colon |
5 | chr11:86963200-86965800 | Weak transcription | Rectal Smooth Muscle | rectum |
6 | chr11:86963200-86969400 | Weak transcription | Adipose Nuclei | Adipose |
7 | chr11:86963600-86964400 | Enhancers | HUVEC | blood vessel |
8 | chr11:86963800-86964400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
9 | chr11:86963800-86964600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr11:86964000-86964200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr11:86964000-86964400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr11:86964400-86966200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr11:86964400-86969400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr11:86964400-86969400 | Weak transcription | HUVEC | blood vessel |
15 | chr11:86964400-86970800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr11:86964600-86970800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |